Epigenetic Mechanisms in Breast Cancer Therapy and Resistance

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance is an authoritative, concise guide for clinicians, researchers, and advanced students seeking a clear, up‑to‑date synthesis of how epigenetic processes shape breast cancer outcomes. Opening with a compelling overview, this book illuminates the molecular switches — DNA methylation, histone modification, chromatin remodeling, and non‑coding RNAs — that influence response to endocrine therapy, chemotherapy, and targeted agents.

Readers will find lucid explanations of how epigenetic alterations drive treatment resistance, practical discussions of emerging predictive biomarkers, and balanced evaluations of epigenetic drugs in clinical development. The text bridges bench and bedside with case studies and translational insights that inform trial design, diagnostic strategy, and patient management. Whether you’re working in a tertiary oncology center in North America, a research lab in Europe, or a clinical program in Asia-Pacific, the book’s global perspective helps translate complex science into actionable approaches.

Packed with clear figures, clinical correlations, and evidence-based recommendations, this volume empowers oncologists and translational researchers to recognize epigenetic signatures of resistance, consider combination strategies, and prioritize biomarkers for personalized care. It’s an essential resource for those engaged in precision oncology, drug development, and molecular diagnostics.

Practical, authoritative, and written in an accessible professional tone, Epigenetic Mechanisms in Breast Cancer Therapy and Resistance is the ideal reference for anyone aiming to stay at the forefront of breast cancer research and treatment. Order your copy today to deepen your understanding of how epigenetics is reshaping therapeutic strategy and patient outcomes worldwide.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.